3ZMG | Hydrolase | date | Feb 08, 2013 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Bace-1 In Complex With Chemical Ligand | ||||||||||||||
authors | D.W.Banner, A.Kuglstatter, J.Benz, M.Stihle | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Beta-Secretase 1 Chain: A Fragment: Extracellular, Residues 46-454 Synonym: 3.4.23.46, Aspartyl Protease 2, Asp2, Asp 2, Beta- Amyloid Precursor Protein Cleaving Enzyme 1, Beta-Site App Enzyme 1, Memapsin-2, Membrane-Associated Aspartic Protease Ec: 3.4.23.46 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 61 2 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.74 Å | ||||||||||||
ligand | 6Z0, DMS, NA | enzyme | Hydrolase E.C.3.4.23.46 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | beta-Secretase (BACE1) Inhibitors with High In Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease., Hilpert H, Guba W, Woltering TJ, Wostl W, Pinard E, Mauser H, Mayweg AV, Rogers-Evans M, Humm R, Krummenacher D, Muser T, Schnider C, Jacobsen H, Ozmen L, Bergadano A, Banner DW, Hochstrasser R, Kuglstatter A, David-Pierson P, Fischer H, Polara A, Narquizian R, J Med Chem. 2013 Apr 16. PMID:23590342 |
Data retrieval |
View 3ZMG in 3D |
Visual 3D analysis of 3ZMG |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3ZMG |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |